HEMO-INTEGRA: Integrated Intraoperative Hemodynamic Monitoring During Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Study
HEMO-INTEGRA
HEMO-INTEGRA: Feasibility and Description of an Integrated Intraoperative Hemodynamic Monitoring System for Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Observational Study
1 other identifier
observational
30
1 country
1
Brief Summary
HEMO-INTEGRA is a software system that integrates four domains of intraoperative hemodynamic monitoring in a single dashboard during cardiac surgery with cardiopulmonary bypass (CPB): (1) ventricular-arterial coupling (VAC) analysis using the Balan 2026 method; (2) tissue perfusion and oxygen delivery (EPOC module with Q10 temperature correction); (3) neuromonitoring (NIRS/BIS); and (4) systemic venous congestion assessment via VExUS-TEE (Waldron 2024 method). This pilot observational study evaluates the feasibility and completeness of data capture using HEMO-INTEGRA across five perioperative time points (T0: pre-CPB; T1: early CPB; T2: mid-CPB; T3: rewarming; T4: post-CPB) in adult patients undergoing elective cardiac surgery at Clinica Medellin Sede Occidente, Medellin, Colombia. The system operates in parallel with standard monitoring and does not modify clinical management. No additional procedures are performed on participants beyond standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2026
CompletedFirst Submitted
Initial submission to the registry
June 27, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
July 6, 2026
June 1, 2026
6 months
June 27, 2026
June 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Data Capture Completeness
Proportion of cases with complete data capture across all five intraoperative time points (T0 to T4) for all four HEMO-INTEGRA monitoring modules: ventricular-arterial coupling, tissue perfusion, neuromonitoring, and venous congestion assessment.
Intraoperative (0 to 6 hours)
Study Arms (1)
HEMO-INTEGRA Cohort
Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass monitored with the HEMO-INTEGRA integrated hemodynamic monitoring system across five intraoperative time points (T0 to T4). Intervention Name : HEMO-INTEGRA v2.0 Software system for integrated intraoperative hemodynamic monitoring integrating ventricular-arterial coupling (Balan 2026), tissue perfusion (EPOC/Q10), neuromonitoring (NIRS/BIS), and venous congestion (VExUS-TEE). Operates in parallel with standard care without modifying clinical management.
Eligibility Criteria
Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass at Clinica Medellin Sede Occidente, Medellin, Colombia.
You may qualify if:
- \- Adult patients 18 years or older scheduled for elective cardiac surgery with cardiopulmonary bypass
- Standard intraoperative TEE and arterial line monitoring in place
- Written informed consent obtained
You may not qualify if:
- \- Emergency surgery
- Off-pump cardiac surgery (OPCAB)
- Inability to obtain adequate TEE window
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinica Medellin Sede Occidente
Medellín, Antioquia, Colombia
Study Officials
- PRINCIPAL INVESTIGATOR
Hernan D Castro-Arias, MD MSc
Clinica Medellin Sede Occidente, Grupo Quiron Salud
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Cardiac Anesthesiologist and Principal Investigator
Study Record Dates
First Submitted
June 27, 2026
First Posted
July 6, 2026
Study Start
May 27, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
July 6, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to the pilot nature of this study and local institutional privacy regulations. Aggregate results will be reported in peer-reviewed publications.